Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Natural killer cell deficiency in patients with non-Hodgkin lymphoma after lung transplantation.
Baychelier F, Achour A, Nguyen S, Raphael M, Toubert A, Besson C, Arnoux A, Roos-Weil D, Marty M, Chapelier A, Samuel D, Debré P, Vieillard V; Study of Cancers After Solid Organs Transplants (K-GREF) Study Group. Baychelier F, et al. Among authors: nguyen s. J Heart Lung Transplant. 2015 Apr;34(4):604-12. doi: 10.1016/j.healun.2014.09.038. Epub 2014 Oct 2. J Heart Lung Transplant. 2015. PMID: 25476847
[Immunomonitoring of patients treated with CAR-T cells for hematological malignancy: Guidelines from the CARTi group and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Rubio MT, Varlet P, Allain V, Ballot C, Cuffel A, Deschamps M, Ferrand C, Foguenne J, Forcade E, Huynh A, Guihot A, Latouche JB, Lemarie C, Martinroche G, Morin F, Nguyen S, Schmit K, Servais S, Simonetta F, Yakoub-Agha I, Caillat Zucman S. Rubio MT, et al. Among authors: nguyen s. Bull Cancer. 2021 Dec;108(12S):S53-S64. doi: 10.1016/j.bulcan.2021.04.008. Epub 2021 Jul 9. Bull Cancer. 2021. PMID: 34253335 French.
FLAMSA-Busulfan-Melphalan as a Sequential Conditioning Regimen in HLA-Matched or Haploidentical Hematopoietic Stem Cell Transplantation for High-Risk Myeloid Diseases.
Jondreville L, Roos-Weil D, Uzunov M, Boussen I, Grenier A, Norol F, Morel V, Nguyen S, Souchet L. Jondreville L, et al. Among authors: nguyen s. Transplant Cell Ther. 2021 Nov;27(11):915.e1-915.e8. doi: 10.1016/j.jtct.2021.07.018. Epub 2021 Jul 28. Transplant Cell Ther. 2021. PMID: 34329755 Free article.
CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC network.
Alcantara M, Houillier C, Blonski M, Rubio MT, Willems L, Rascalou AW, Le Garff-Tavernier M, Maloum K, Bravetti C, Souchet L, Roos-Weil D, Morel V, Uzunov M, Metz C, Dhib-Charfi M, Nguyen S, Shor N, Psimaras D, Weiss N, Jacque N, Solorzano S, Gauthier N, Le Cann M, Norol F, Soussain C, Choquet S. Alcantara M, et al. Among authors: nguyen s. Blood. 2022 Feb 3;139(5):792-796. doi: 10.1182/blood.2021012932. Blood. 2022. PMID: 34871363 Free PMC article. No abstract available.
CAR-NK Cells: A Chimeric Hope or a Promising Therapy?
Sabbah M, Jondreville L, Lacan C, Norol F, Vieillard V, Roos-Weil D, Nguyen S. Sabbah M, et al. Among authors: nguyen s. Cancers (Basel). 2022 Aug 8;14(15):3839. doi: 10.3390/cancers14153839. Cancers (Basel). 2022. PMID: 35954502 Free PMC article. Review.
2,298 results